IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CAPETTI, AMEDEO FERDINANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.414
AS - Asia 2.001
EU - Europa 1.830
SA - Sud America 210
AF - Africa 123
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.280
CN - Cina 642
SG - Singapore 496
GB - Regno Unito 427
IT - Italia 377
DE - Germania 253
VN - Vietnam 170
IN - India 165
HK - Hong Kong 139
BD - Bangladesh 131
BR - Brasile 131
SE - Svezia 121
RU - Federazione Russa 119
FR - Francia 117
CA - Canada 112
NL - Olanda 88
ES - Italia 66
IE - Irlanda 53
JP - Giappone 48
TR - Turchia 48
FI - Finlandia 45
ID - Indonesia 37
CI - Costa d'Avorio 35
ZA - Sudafrica 32
DK - Danimarca 27
PL - Polonia 26
BE - Belgio 23
KR - Corea 23
AR - Argentina 22
CO - Colombia 21
MX - Messico 18
AU - Australia 17
TW - Taiwan 17
UA - Ucraina 16
PH - Filippine 14
VE - Venezuela 14
CH - Svizzera 13
ET - Etiopia 11
AT - Austria 10
TH - Thailandia 10
GR - Grecia 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
CL - Cile 7
PK - Pakistan 7
UG - Uganda 7
EC - Ecuador 6
KE - Kenya 6
MY - Malesia 6
BW - Botswana 5
IL - Israele 5
IQ - Iraq 5
IR - Iran 5
MK - Macedonia 5
RO - Romania 5
BG - Bulgaria 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
EU - Europa 3
NG - Nigeria 3
PY - Paraguay 3
TZ - Tanzania 3
UZ - Uzbekistan 3
BJ - Benin 2
BY - Bielorussia 2
CM - Camerun 2
CY - Cipro 2
DZ - Algeria 2
GH - Ghana 2
GM - Gambi 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
MW - Malawi 2
NP - Nepal 2
TD - Ciad 2
TN - Tunisia 2
UY - Uruguay 2
ZW - Zimbabwe 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
JO - Giordania 1
KW - Kuwait 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
PA - Panama 1
PE - Perù 1
Totale 6.599
Salva come PNG Salva come JPEG
Città #
Singapore 298
Southend 298
Ashburn 246
Chandler 203
Milan 135
Houston 120
San Jose 120
Hong Kong 117
Beijing 116
Fairfield 109
Frankfurt am Main 104
Redwood City 90
Seattle 73
New York 71
Council Bluffs 64
Dallas 63
Toronto 61
Los Angeles 56
The Dalles 52
Princeton 51
Wilmington 51
Shanghai 50
Dublin 49
Ann Arbor 47
Hanoi 46
Woodbridge 45
Santa Clara 41
Ho Chi Minh City 40
Cambridge 39
Abidjan 35
Boardman 35
Nanjing 31
Hefei 30
Bengaluru 29
Helsinki 29
Jakarta 28
Lauterbourg 28
Dearborn 25
Munich 25
Buffalo 24
Guangzhou 24
Warsaw 24
Columbus 22
Brussels 21
Des Moines 21
Tokyo 19
Istanbul 18
São Paulo 18
Moscow 17
Mumbai 17
Phoenix 17
Rotterdam 17
Cangzhou 16
Jinan 16
Kiez 15
Hyderabad 14
Mountain View 13
Ottawa 13
Rome 13
Shenyang 13
Taipei 13
Valencia 13
Nuremberg 12
London 11
Fuzhou 10
Kunming 10
Montreal 10
Barcelona 9
Changsha 9
Nanchang 9
Nihon'odori 9
Turku 9
Athens 8
Central District 8
Delhi 8
Duncan 8
Durban 8
Haiphong 8
Hangzhou 8
Manchester 8
Munro 8
Santiago de Cali 8
Seoul 8
Turin 8
Amsterdam 7
Chennai 7
Oxford 7
Washington 7
Ankara 6
Atlanta 6
Bari 6
Chicago 6
Da Nang 6
Falls Church 6
Fremont 6
Naples 6
New Haven 6
Nürnberg 6
Philadelphia 6
Piscataway 6
Totale 3.842
Salva come PNG Salva come JPEG
Nome #
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients 811
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders 589
Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art 427
Antiretroviral therapy through barriers : a prominent role for nanotechnology in HIV-1 eradication from sanctuaries 400
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 373
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 284
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 284
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 253
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 228
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 219
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 199
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 196
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents 196
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort 193
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 176
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 173
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 169
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects 166
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data 159
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 153
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 134
Effects of ritonavir and cobicistat on dolutegravir exposure : when the booster can make the difference 133
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 129
OPERA : responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy 124
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV 120
OPERA : use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients 115
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG 113
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? 113
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 110
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 96
Estimating long COVID-19 prevalence across definitions and forms of sample selection 9
Totale 6.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022554 61 35 34 33 30 38 45 39 89 38 21 91
2022/2023647 69 89 66 69 46 113 15 49 47 18 38 28
2023/2024565 37 53 38 51 123 63 20 34 26 25 41 54
2024/20251.007 38 84 23 113 88 57 34 79 48 117 109 217
2025/20262.044 207 138 214 169 200 119 346 50 137 135 283 46
Totale 6.844